Good day and welcome to the MTBC First Quarter 2019 Earnings Conference Call and Webcast. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Shruti Patel, General Counsel. Please go ahead.

Thank you. Good morning, everyone. Welcome to the MTBC 2019 first quarter conference call. On today's call are Mahmud Haq, our Founder and Executive Chairman; Stephen Snyder our Chief Executive Officer and Director; A. Hadi Chaudhry our President and Director and Bill Korn, our Chief Financial Officer. Before we begin, I would like to remind you that certain statements made during this conference call are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934 as amended. All statements, other than statements of historical fact, made during this conference call are forward-looking statements, including without limitation, statements regarding our expectations and guidance for future financial and operational performance, expected growth, business outlook and potential organic growth and acquisitions. Forward-looking statements may sometimes be identified with words such as will, may, expect, plan, anticipate, upcoming, believe, estimate, or similar terminology and the negative of these terms. Forward-looking statements are not promises or guarantees of future performance and are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. These statements reflect our opinions only as of the date of this presentation and we undertake no obligation to revise these forward-looking statements in light of new information or future events. Please refer to our press release and our reports filed with the Securities and Exchange Commission, where you will find a more comprehensive discussion of our performance and factors that could cause actual results to differ materially from these forward-looking statements. For anyone who dialed in to the call by telephone, who may want to download our first quarter 2019 earnings presentation. Please visit our Investor Relations site ir.mtbc.com, click on Events and download the earnings presentation. Finally, on today's call we may refer to certain non-GAAP financial measures. Please refer to today's press release announcing our full year 2018 results for a reconciliation of these non-GAAP performance measures to our GAAP financial results. With that said, I will now turn the call over to the Chief Executive Officer of MTBC, Stephen Snyder. Steve?

Thank you, Shruti. And thank you everyone for joining us on our first quarter 2019 earnings call. We are pleased to report a strong start to 2019, including revenue of $15.1 million, an increase of 82% from Q1 of 2018 and a $606,000 increase in adjusted EBITDA to $1.6 million, which represents the highest quarterly EBITDA in our company's history. Revenue and adjusted EBITDA were both consistent with our 2019 guidance as we delivered our eighth consecutive quarter of positive adjusted EBITDA. During the five years since our IPO, we grew our revenue at a compound annual growth rate of 37% from $10 million in 2013, to over $50 million in 2018. In addition to our top line growth, we are pleased to double our adjusted EBITDA year-over-year during 2018, while generating positive cash from operations. In recognition of MTBCs tracks record, we are pleased that NASDAQ up listed MTBC from the NASDAQ capital market to its exclusive NASDAQ global market during the first quarter, after concluding that we satisfied a strict financial liquidity and corporate governance standards. We're thankful to our enthusiastic team members and clients for enabling us to achieve this growth and qualify for inclusion in the NASDAQ global market. While our early days were focused on providing manual medical billing and transcription two small practices, over the last 18 years, we've evolved into one of the nation's leading providers of cloud based practice and revenue cycle management, proprietary healthcare IT solutions and integrated technology driven services to healthcare practices. As we've evolved, we've become known in the industry as MT BC, rather than Medical Transcription Billing, Corp., so we were pleased to officially update our name to MTBC during the first quarter to better reflect our company mission and DNA. Moreover, since our last earnings call, we also announced the closing of a small tuck-in transaction. We acquired substantially all the assets of Etransmedia Technology Incorporated and its affiliated companies for less than one half times revenues. Similar to MediGain and Orion, the last two larger businesses that we acquired, Etransmedia recognize the opportunity to be a consolidator in our space. However, Etransmedia like those before it lacked three things that enable us to succeed where others have tried and failed. First, a leading edge proprietary platform; second, a cost efficient global team of experts and third, we have unparalleled experience successfully integrating companies in our highly fragmented space. Etransmedia is emblematic of the type of tuck-in acquisitions that we are positioned to close and integrate, while we continue to work at identifying and selecting the most attractive, larger acquisition targets. I'll now turn the floor over to our President. Hadi?

Thank you, Steve. And thank you everyone for joining us on our first quarter 2019 call. The first quarter marked another exciting chapter in us fully building one of the nation's leading cloud based practice management, revenue cycle and healthcare IT platform. We had a great quarter and remain on track to grow our revenue by 25% or more, when striving to again nearly doubled our adjusted EBITDA year-over-year. During quarter one; we made additional strides in successfully integrating our Orion acquisition. This progress included not only cost reductions, but forward momentum in integrating key operational components of Orion with our larger operations. These combined teams from client success to patient services, coding to credentialing, and finance to HR had laid an even stronger foundation for our growth. We are more capable of succeeding today as the onboard new accounts, whether they are joining us through acquisitions or organic growth. While we only recently acquired Etransmedia, we have already made the key progress at integrating this latest tuck-in transaction. We are also in the process of onboarding our first facility billing in Height Hospital client and we are hopeful that this new relationship will pave the way for our continued expansion into the hospital space. We have an exciting year ahead and we look forward to providing updates as we progress. I will now turn the floor over to our Chief Financial Officer, Bill Korn. Bill?

Thank you, Hardi. Revenue for the first quarter of 2019 was $15.1 million, which represents an increase of 82% compared to $8.3 million in first quarter of 2018. For the first quarter of 2019, our GAAP net loss was $296,000, compared to GAAP net income of $75,000 in first quarter of 2018. The GAAP net loss in the most recent quarter includes non-cash amortization and depreciation expense of $757,000, including $262,000 resulting from the amortization of intangible assets for from the acquisition of Orion during the second half of 2018. It also includes stock based compensation expense of $758,000. The increase in these two GAAP expenses, which are primarily non-cash in nature more than accounts for the difference in our net income year-over-year. A sequential comparison may also be useful this quarter to illustrate the improvements in our GAAP net loss from the integration of our Orion acquisition, which occurred during third quarter 2018. Our GAAP net loss was $296,000 for first quarter of 2019, compared to a GAAP net loss of $576,000 in fourth quarter of 2018. A 49% reduction in our net loss is due to our team quickly and effectively reducing costs associated with Orion's revenue cycle management business. Using our technology were possible, replacing subcontractors with our own offshore employees, downsizing our closing offices and otherwise reducing costs. In the three quarters since this acquisition, we were able to reduce the total operating expense of Orion's RCM business by 59% from their expenses during the quarter before the acquisition. Our GAAP net loss per share was $0.15 based on the net loss attributable to common shareholders, which takes into account the preferred stock dividends declared during the quarter. Adjusted EBITDA for the first quarter of 2019 increased by 62% to $1.58 million, as compared to $974,000…

Thank you, Bill. We had a strong start to 2019, which promises to be another year of record breaking growth and increased profitability. We thank our investors, customers, employees for their continued support. We will now call to floor to questions. Operator?

Thank you. We will now begin the question-and-answer session. [Operator Instructions] And our first question today comes from Eugene Mannheimer with Dougherty & Company. Please go ahead.

Good morning, gentlemen. Congrats on a good quarter here. Good start to the year. I wanted to ask you a little bit about Etransmedia a little bit more. Sounds like the contribution to revenue was, call it 3.5 million based on the multiple - the revenue that you paid. And I understand that's already factored into your guidance for the year. So I guess the question is how much revenue from tuck-ins is contemplated in your outlook? In other words, if you were to close another one like this, I mean, would that necessitate a revision to your full year guidance, and when will the transaction be accretive? Thanks.

Thanks, Gene. And it's - I want to say it's great having you covering us. I think we feel honored having an analyst who covers all scripts and you covered Athena through their growth to a $1billion covering us. So it's great to have you. As far as Etransmedia, as you noted, we paid $1.6 million. And while we haven't given sort of official guidance as to how much revenue to expect, we anticipate that just like Orion we'll get at least twice the continuing revenue to the value that we paid. So yes, that'll be in the $3.5 million annualized range. We recognize that Etransmedia had gone through some hard times before and so our model takes into account the fact that there are some clients who probably looked at other alternatives and at the same time works as hard as possible to keep them with us. And in terms of what we baked to our model, I guess I'd say there are two small paths to growth and one big path to growth. As we continue to sign new organic clients, such as, for example, Height Hospital, those could add pretty significant chunks of revenue. And we've got other new clients that we've been signing. So in some respects, whether we did another Etransmedia deal or did another hospital or large practices, those are sort of a wash as to which one is in there. So I wouldn't specifically say whether we have one or not, I think we're going to continue to - as we look for bigger very accretive deals, we're going to continue to look for organic opportunities that make sense. And when we see tuck-ins like Etransmedia that can get done without breaking a sweat then we'll continue to do those.

Okay, all right. Thank you, Bill. And my follow up question would be on the Orion acquisition now, you stated 59% reduction in OpEx, I think since closing the transaction. Is that - how does that compare with your expectations going into it? And is there still more to go with that one? Thank you.

Yeah. So the 59% on Orion is from the quarter before we closed the transaction. So we looked at what was their expense in second quarter of last year. We bought them on July 1, so you won't see the whole 59 in our numbers because we didn't take on some cost even when we started. But I'd say it's very consistent with what we expected when we purchased MediGain, looking out a total of four quarters that was a 62% decrease in expenses from the quarter before we bought them. So now three quarters into Orion we're at 59. As we look at the current second quarter, there are still reductions that happened in the middle of first quarter where you got a partial quarter effects and so you'll see a little bit more. So I think this will be very similar. And again, our team is focused primarily on the cost reductions in Orion's revenue cycle management business. Orion has two other lines that were actually both positively contributing to profits before we bought them. There's a group purchasing organization, it generates a little over a million a year in revenue and the GPO has essentially very little cost with it. Because physicians are buying vaccines from Merck and Sanofi, we're getting a quarterly rebate check. So there's no cost. So there's really not much you can do to reduce the costs there. And finally, Orion was managing three physician practices. So we've got 100 employees across five offices in the Midwest, who are nurses and other caregivers. And again, there's no real plans to change that model. It's nicely profitable. It's a core stream of revenue that we don't have to do much about, but we wouldn't really look at doing things in that particular business. Does that really the same kind of synergies or opportunities to change the structure there?

Okay, very good. Thank you, Bill, congrats.

Thanks, Gene.

[Operator Instructions] And our next question comes from Brian Marckx with Zacks Investment Research. Please go ahead.

Good morning, guys and congrats on the quarter. Bill, wondering if you can give us the breakdown of the three business segments in terms of revenue?

So thanks, Brian. So I guess when you say the three business segments, I think if you look in the 10-K and you'll find the same thing as we go into to this 10-Q. We actually divide ourselves in two business segments, healthcare IT and practice management and the practice management business last year, for the for the half of the year was roughly $6 million revenue, is roughly a constant business. So it's roughly about $12 billion of revenue per year. The remainder of the revenue is in our healthcare IT business. And that includes about $1 million annually of GPO revenue. It includes traditional revenue cycle management, it includes some printing, unveiling and other ancillary services. We actually give a little bit more of a detail of revenue in one of the notes, but in terms of providing segments and a full P&L, we break it into two segments. And in large measure the practice management business is separated again because the cost structure, the economics are very different. So we feel it's useful to separate that out and that will have different margin and growth expectations going forward.

Okay, so the itemization in the Q will be the same as itemization was in the K, is that right?

That's right. There'll be a note that I believe is called disaggregation of revenue that might have, say seven categories in it that gives you a little more granular detail on revenue. And again, a lot of the same people are doing the same thing. So it's really hard to separate out the costs.

Yeah, okay. I Understand, yeah. In terms of G&A expense in Q1, it was about $700,000 less than what we were anticipating. Was the G&A expense - where you thought it would shake out? Or was it may be lower than where you anticipated? And can you give us a little bit help with where you think it goes into Q2?

Sure. So I would say, G&A was pretty much on track with what we were planning for and managing for. As you know when we buy companies, we've always got to look at what was it that caused that. If we're buying companies and we're paying a low price that they weren't doing everything right. What were they doing that that we could change that wouldn't negatively impact customers? And the simplest thing is close big offices that you don't need, find that back office expenses doesn't really impact the customer and find ways to do it more cost effectively. I think when we put together our plan, we had, even at the time that we closed Orion, we had specific steps in mind and specific timelines. So I think we're actually executing on that pretty well against plan. We also recognize that when portraying out to the street, we don't necessarily want to tip our hands completely and tell everybody everything that we possibly could do. We like to have a little bit of room because things happen that are unforeseen. And so if I then think about G&A going forward and I think about profitability for the for the rest of the year, on April 1, we acquired Etransmedia. Now again, before we acquired Etransmedia, their business was losing money. We've already taken lots of steps. But I'd say if I think about the full year 2019, the overall expense, the overall profitability will be exactly what we expected. If I look at Q2, it will probably - the Etransmedia will probably have a little bit of a drag on Q2 that will neutralize and maybe be a little positive in Q3, and then we'll be really creative in Q4. So again, it's hard. If we bought a company that was generating 30% profit margins, the amount we got to pay would be a lot more. If you want to be able to buy these things at a real discount, you've got to assume that the day you close the transaction, you look at and in their case, for example, three big offices where there's opportunity to sublease out a lot of unused space or maybe get out of things. So there's a lot of that that's happening even in the 35 days since we completed that transaction.

Okay, great. Thank you, Bill.

Sure.

And this will conclude our question and answer session. I like to turn the conference back over just Shruti Patel for any closing remarks.

Thank you. Thank you, everyone for joining our call. We hope that you'll have a great day and we'll see you soon. Thank you.

The conference is now concluded. Thank you for attending today's presentation. You may now disconnect